158 related articles for article (PubMed ID: 31340988)
1. Role of
Kailashiya V; Sharma HB; Kailashiya J
J Clin Pathol; 2019 Oct; 72(10):659-662. PubMed ID: 31340988
[TBL] [Abstract][Full Text] [Related]
2. CTLA4 gene variants in autoimmunity and cancer: a comparative review.
Ghaderi A
Iran J Immunol; 2011 Sep; 8(3):127-49. PubMed ID: 21931200
[TBL] [Abstract][Full Text] [Related]
3. Association of CTLA4 exon-1 polymorphism with the tumor necrosis factor-α in the risk of systemic lupus erythematosus among South Indians.
Katkam SK; Kumaraswami K; Rupasree Y; Thishya K; Rajasekhar L; Kutala VK
Hum Immunol; 2016 Feb; 77(2):158-64. PubMed ID: 26582004
[TBL] [Abstract][Full Text] [Related]
4. The CTLA4 +49 A/G (rs231775) polymorphism influences susceptibility to SLE in South Indian Tamils.
Devaraju P; Gulati R; Singh BK; Mithun CB; Negi VS
Tissue Antigens; 2014 Jun; 83(6):418-21. PubMed ID: 24758310
[TBL] [Abstract][Full Text] [Related]
5. Association between the cytotoxic T-lymphocyte antigen-4 mutations and the susceptibility to systemic lupus erythematosus; Contribution markers of inflammation and oxidative stress.
Tanhapour M; Vaisi-Raygani A; Bahrehmand F; Khazaei M; Kiani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):56-61. PubMed ID: 27894401
[TBL] [Abstract][Full Text] [Related]
6. Lupus susceptibility region containing CTLA4 rs17268364 functionally reduces CTLA4 expression by binding EWSR1 and correlates IFN-α signature.
Qi YY; Zhao XY; Liu XR; Wang YN; Zhai YL; Zhang XX; Wang XY; Zhang LJ; Zhao YF; Cui Y; Ning XH; Zhou XJ
Arthritis Res Ther; 2021 Nov; 23(1):279. PubMed ID: 34736521
[TBL] [Abstract][Full Text] [Related]
7. CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus.
Aguilar F; Torres B; Sánchez-Román J; Núñez-Roldán A; González-Escribano MF
Hum Immunol; 2003 Oct; 64(10):936-40. PubMed ID: 14522090
[TBL] [Abstract][Full Text] [Related]
8. Association between 318C/T polymorphism of the CTLA-4 gene and systemic lupus erythematosus in Iranian patients.
Shojaa M; Aghaie M; Amoli M; Javid N; Shakeri F; Khashayar P; Tabarraei A; Keshtkar AA; Joshaghani HR; Kouroshnia A; Qorbani M; Mahmoudi F; Mohebbi R; Ranjbarpour N
Int J Rheum Dis; 2017 Dec; 20(12):2040-2044. PubMed ID: 24400885
[TBL] [Abstract][Full Text] [Related]
9. Association between PDCD1, CTLA4, and MECP2 gene polymorphisms and systemic lupus erythematosus in the Chinese Northern Han.
Dong HR; Li HS; Wang SC; Balin QM; Chang PY
Genet Mol Res; 2015 Dec; 14(4):17567-73. PubMed ID: 26782401
[TBL] [Abstract][Full Text] [Related]
10. Association of AIRE (rs2075876), but not CTLA4 (rs231775) polymorphisms with systemic lupus erythematosus.
Alghamdi SA; Kattan SW; Toraih EA; Alrowaili MG; Fawzy MS; Elshazli RM
Gene; 2021 Feb; 768():145270. PubMed ID: 33122082
[TBL] [Abstract][Full Text] [Related]
11. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus.
Barreto M; Santos E; Ferreira R; Fesel C; Fontes MF; Pereira C; Martins B; Andreia R; Viana JF; Crespo F; Vasconcelos C; Ferreira C; Vicente AM
Eur J Hum Genet; 2004 Aug; 12(8):620-6. PubMed ID: 15138458
[TBL] [Abstract][Full Text] [Related]
12. CTLA-4 gene polymorphism and the risk of systemic lupus erythematosus in the Chinese population.
Taha Khalaf A; Song JQ; Gao TT; Yu XP; Lei TC
J Biomed Biotechnol; 2011; 2011():167395. PubMed ID: 21915163
[TBL] [Abstract][Full Text] [Related]
13. Brief report: increased expression of a short splice variant of CTLA-4 exacerbates lupus in MRL/lpr mice.
Ichinose K; Zhang Z; Koga T; Juang YT; Kis-Tóth K; Sharpe AH; Kuchroo V; Crispín JC; Tsokos GC
Arthritis Rheum; 2013 Mar; 65(3):764-9. PubMed ID: 23203389
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
[TBL] [Abstract][Full Text] [Related]
15. CTLA4 Gene Polymorphism and its Association with Disease Occurrence, Clinical Manifestations, Serum Markers and Cytokine Levels in SLE Patients from North India.
Kailashiya V; Singh U; Kailashiya J
Indian J Dermatol; 2022; 67(3):311. PubMed ID: 36386077
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 -1722T/C polymorphism and systemic lupus erythematosus susceptibility: a meta-analysis involving ten separate studies.
Zhu JM; Li BK; Chen GM; Feng CC; Cen H; Fan YG; Wang B; Pan HF; Ye DQ
Immunol Invest; 2013; 42(2):91-105. PubMed ID: 23323522
[TBL] [Abstract][Full Text] [Related]
17. Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.
Paterson AM; Lovitch SB; Sage PT; Juneja VR; Lee Y; Trombley JD; Arancibia-Cárcamo CV; Sobel RA; Rudensky AY; Kuchroo VK; Freeman GJ; Sharpe AH
J Exp Med; 2015 Sep; 212(10):1603-21. PubMed ID: 26371185
[TBL] [Abstract][Full Text] [Related]
18. No evidence of association between CTLA-4 polymorphisms and systemic lupus erythematosus in Iranian patients.
Shojaa M; Javid N; Amoli M; Shakeri F; Samaei NM; Aghaie M; Khashayar P; Livani S
Int J Rheum Dis; 2013 Dec; 16(6):681-4. PubMed ID: 24382279
[TBL] [Abstract][Full Text] [Related]
19. What did we learn from CTLA-4 insufficiency on the human immune system?
Mitsuiki N; Schwab C; Grimbacher B
Immunol Rev; 2019 Jan; 287(1):33-49. PubMed ID: 30565239
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 SNPs (CT60A/G, -1722T/C, -1661G/A, and -318C/T) and systemic lupus erythematosus: a meta-analysis.
Zhu Y; Wang J; Feng X
Crit Rev Eukaryot Gene Expr; 2014; 24(2):89-100. PubMed ID: 24940764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
